Model averaging in the presence of structural uncertainty about treatment effects: Influence on treatment decision and expected value of information

Value in Health

Volumn 14, Issue 2, 2011, Pages 205-218

  Price, Malcolm J ^a   Welton, Nicky J ^a   Briggs, Andrew H ^b   Ades, A E ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Asthma; Bayesian; Cost effectiveness analysis; Evidence synthesis; Markov model; Model averaging; Parameterisation; Randomized controlled trial; Structural uncertainty; Treatment; Value of information; WinBUGs

Indexed keywords

ARTICLE; ASTHMA; AVERAGING; BAYES THEOREM; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; HEALTH ECONOMICS; HUMAN; INFORMATION; MEDICAL DECISION MAKING; MONTE CARLO METHOD; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; TREATMENT FAILURE; TREATMENT OUTCOME; UNCERTAINTY;

EID: 79959591126     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2010.08.001     Document Type: Article

References (46)

1. Honkanen LA, Schackman BR, Mushlin AI, Lachs MS. A costbenefit analysis of external hip protectors in the nursing home setting. J Am Geriatr Soc 2005;53:190-7. (Pubitemid 41632543)
2. Iglesias CP, Torgerson DJ, Bearne A, Bose U. The cost utility of bisphosphonate treatment in established osteoporosis. Q J Med 2002;95:305-11. (Pubitemid 34537763)
3. Konski A. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer. Int J Radiat Oncol Biol Phys 2004;60:1373-8. (Pubitemid 39601854)
4. Kanis JA, Borgstrom F, Johnell O, Jonsson B. Costeffectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women. Osteoporos Int 2004;15:862-71. (Pubitemid 39506452)
5. TenBrook JA, Wolf MP, Hoffman SN, et al. Should betablockers be given to patients with heart disease and peanutinduced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004;113:977-82. (Pubitemid 38608610)
6. Coyle D, Cranney A, Lee KM, et al. Cost effectiveness of nasal calcitonin in postmenopausal women-use of Cochrane collaboration methods for meta-analysis within economic evaluation. Pharmacoeconomics 2001;19:565-75. (Pubitemid 32488744)
7. Briggs AH, Ades AE, Price MJ. Probabilistic sensitivity analysis for decision trees with multiple branches: Use of the Dirichlet distribution in a Bayesian framework. Med Decis Making 2003;23:341-50. (Pubitemid 36899100)
8. Price MJ, Welton NJ, Ades AE. Parameterisation of treatment effects for meta-analysis in Multistate Markov models. Stat Med 2011;30:140-51.
9. Price MJ, Welton NJ, Ades AE. Modelling Treatment effects in discrete-time Markov data from clinical trials of asthma. Proceedings of the Society for Medicalm Decision Making 10th Biennial European Conference; June 11-13, 2006; Birmingham, UK.
10. Welton NJ, Ades AE. Estimation of markov chain transition probabilities and rates from fully and partially observed data: Uncertainty propagation, evidence synthesis and model calibration. Med Decis Making 2005;25:633-45. (Pubitemid 41667132)
11. Spiegelhalter DJ, Best NG, Carlin BR, van der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Series B Stat Methodol 2002;64:583-616.
12. Claeskens G, Lid Hjort N. Model Selection and Model Averaging. Cambridge, UK: Cambridge University Press, 2008.
13. Briggs A, Sculper M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford, UK: Oxford University Press, 2006.
14. Claxton K, Neumann PJ, Araki S, Weinstein MC. Bayesian value-of-infomation analysis-an application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care 2001;17:38-55. (Pubitemid 32381740)
15. Raiffa H, Schaifer R. probability and statistics for business decisions.New York: McGraw-Hill, 1959.
16. Hoeting JA, Madigan D, Raftery AE, Volinsky CT. Bayesian model averaging: A tutorial. Stat Sci 1999;14:382-401.
17. Abrams K. Regression models for survival data. In: Everitt BS, Dunn G, eds., Statistical Analysis of Medical Data - New Developments. London: Arnold, 1998.
18. Abrams K, Sutton A, Cooper N, Lambert P. Accounting for statistical model uncertainty in economic decision models - A Bayesian Approach. Proceedings of the International Health Economics Association 6th World Congress; July 8-12, 2007, Copenhagen, Denmark.
19. Bojke L, Claxton K, Sculpher M, Palmer S. Characterizing structural uncertainty in decision analytic models: A review and application of methods. Value Health 2009;12:739-49.
20. Draper D. Assessment and Propagation of Model Uncertainty. J R Stat Soc Series B Stat Methodol 1995;57:45-97.
21. Jackson CH, Thompson SG, Sharples LD. Accounting for uncertainty in health economic decision models by using model averaging. J R Stat Soc Ser A Stat Soc 2009;172:383-404.
22. Jackson CH, Sharples LD, Thompson SG. Structural and parameter uncertainty in Bayesian cost-effectiveness models. J R Stat Soc Ser C Appl Stat 2010;59:233-53.
23. Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making 1998;18:95-109. (Pubitemid 28041646)
24. Schlaiffer R. Probability and statistics for business decisions. New York: McGraw-Hill, 1958.
25. Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ 2005; 331:897-900. (Pubitemid 41502718)
26. Higgins JPT, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med 1996;15:2733-49. (Pubitemid 27011054)
27. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004;23:3105-24. (Pubitemid 39334902)
28. Congdon P. Bayesian Methods for Categorical Data. Chichester: Wiley, 2005.
29. Yu F, Morgenstern H, Hurwitz E, Berlin TR. Use of a Markov transition model to analyse longitudinal low-back pain data. Stat Methods Med Res 2003;12:321-31. (Pubitemid 36992598)
30. Grimmet GR, Stirzaker DR. Probability and Random Processes. Oxford University Press: Oxford, 2006.
31. Taylor H, Karlin S. An Introduction to Stochastic Modeling (3rd Ed.). London: Academic Press, 2006.
32. Claeskens G, Lid Hjort N. Model Selection and Model Averaging. Cambridge, UK: Cambridge University Press, 2008.
33. Hoskins G, Smith B, Thomson C, et al. The cost implications of an asthma attack. Pediatr Asthma Allergy Immunol 1998; 12:193-8. (Pubitemid 29067322)
34. Price MJ, Briggs AH. Development of an economic model to assess the cost effectiveness of asthma management strategies. Pharmacoeconomics 2002;20:183-94. (Pubitemid 34454643)
35. Spiegelhalter D.J., Abrams KR, Myles P.M. Bayesian Approaches to Clinial Trials and Health-Care Evaluation. Chichester: Wiley, 2004.
36. Briggs A, Sculpher M. An introduction to markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397-409. (Pubitemid 28140699)
37. The BUGS Project. The BUGS Project. http://www.mrc-bsu cam ac.uk/bugs/welcome shtml 2007. Available from: URL: Http://www.mrc-bsu.cam.ac. uk/bugs/welcome.shtml [Accessed September 10, 2010].
38. Lunn D. winBUGS Differential Interface WBDiff. http://www. winbugs-development.org.uk/wbdiff html 2004. Available from: URL: Http://www.winbugs-development.org.uk/ wbdiff.html [Accessed September 9, 2010].
39. Black WC. The ce plane-a graphic representation of costeffectiveness. Med Decis Making 1990;10:212-4.
40. Ades AE, Claxton K, Sculpher M. Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. Health Econ 2006;15:373-81.
41. Parmigiani G. Modelling in medical decision making: A Bayesian approach. Chichester: Wiley, 2002.
42. Cooper NJ, Abrams KR, Sutton AJ, et al. A Bayesian approach to Markov modelling in cost-effectiveness analyses: Application to taxane use in advanced breast cancer. J R Stat Soc Ser A Stat Soc 2003;166:389-405. (Pubitemid 37230280)
43. Green PJ. Reversible jump Markov chain Monte Carlo computation and Bayesian model determination. Biometrika 1995;82:711-32.
44. Schwarz G. Estimating dimension of a model. Ann Stat 1978; 6:461-4.
45. Celeux G, Forbes F, Robert CP, Titterington DM. Deviance Information criteria for missing data models. Bayesian Anal 2006;1:681-6.
46. Madigan D, Raftery AE. Model selection and accounting for model uncertainty in graphical models using occams window. J Am Stat Assoc 1994;89:1535-46.